뇌신경재활 영역에서 치매의 이해와 역할

키워드

참고문헌 (50)

1. Querfurth HW, "Alzheimer's disease", N Engl J Med, 362, pp.329~344 (2010)
2. Present Report for Management of Dementia, "Department of Social Work", National Assembly Budget Office, ~ (2014)
3. Cheong HK, "Dementia: a clinical approach", pp.49~61 (2011), Academia
4. Mayeux R, "Clinical practice. Early Alzheimer's disease", N Engl J Med, 362, pp.2194~2201 (2010)
5. Plassman BL, "Prevalence of cognitive impairment without dementia in the United States", Ann Intern Med, 148, pp.427~434 (2008)
6. Petersen RC, "Vitamin E and donepezil for the treatment of mild cognitive impairment", N Engl J Med, 352, pp.2379~2388 (2005)
7. Levey A, "Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease", Clin Ther, 28, pp.991~1001 (2006)
8. 정현강, "일차의료 현장에서 치매의 진단 및 치료", 대한의사협회지, 56(12), pp.1104~1112 (2013), 대한의사협회
9. Kales HC, "Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel", J Am Geriatr Soc, 62, pp.762~769 (2014)
10. Mitchell AJ, "CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies", J Neurol Neurosurg Psychiatry, 80, pp.966~975 (2009)
11. Dickerson BC, "Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment", Arch Gen Psychiatry, 64, pp.1443~1450 (2007)
12. 신준현, "치매의 진단: 신경심리검사", Korean Journal of Family Medicine, 31(4), pp.253~266 (2010), 대한가정의학회
13. Pary R, "Dementia: what to do", South Med J, 83, pp.1182~1189 (1990)
14. Mucke L, "Neuroscience: Alzheimer's disease", Nature, 461, pp.895~897 (2009)
15. Andreasen N, "Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice", Arch Neurol, 58, pp.373~379 (2001)
16. Sjogren M, "Both total and phosphorylated tau are increased in Alzheimer's disease", J Neurol Neurosurg Psychiatry, 70, pp.624~630 (2001)
17. Kohnken R, "Detection of tau phosphorylated at threonine 231in cerebrospinal fluid of Alzheimer's disease patients", Neurosci Lett, 287, pp.187~190 (2000)
18. Schroeter ML, "Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients", Neuroimage, 47, pp.1196~1206 (2009)
19. Rosano C, "Neuroimaging differences between older adults with maintained versus declining cognition over a 10-year period", Neuroimage, 62, pp.307~313 (2012)
20. Yuan Y, "Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis", AJNR Am J Neuroradiol, 30, pp.404~410 (2009)
21. National comprehensive plan for management of dementia, "Ministry of Health and Welfare", Ministry of Health and Welfare, ~ (2012)
22. Ferri CP, "Global prevalence of dementia: a Delphi consensus study", Lancet, 366, pp.2112~2117 (2005)
23. Mayeux R, "Epidemiology of neurodegeneration", Annu Rev Neurosci, 26, pp.81~104 (2003)
24. Duyckaerts C, "Classification and basic pathology of Alzheimer disease", Acta Neuropathol, 118, pp.5~36 (2009)
25. Ikeda M, "Increased prevalence of vascular dementia in Japan: a community-based epidemiological study", Neurology, 57, pp.839~844 (2001)
26. Al-Qazzaz NK, "Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment", Neuropsychiatr Dis Treat, 10, pp.1677~1691 (2014)
27. Kanekar S, "Neuroimaging of vascular dementia", Radiol Clin North Am, 52, pp.383~401 (2014)
28. Kuruppu DK, "Young-onset dementia", Semin Neurol, 33, pp.365~385 (2013)
29. Baumer D, "Advances in motor neurone disease", J R Soc Med, 107, pp.14~21 (2014)
30. Harciarek M, "Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes", Int Rev Psychiatry, 25, pp.178~196 (2013)
31. Morris JC, "Dementia update 2005", Alzheimer Dis Assoc Disord, 19, pp.100~117 (2005)
32. Molano JR, "Dementia with Lewy bodies", Semin Neurol, 33, pp.330~335 (2013)
33. Donaghy PC, "The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis", Alzheimers Res Ther, 6, pp.46~ (2014)
34. Hansen RA, "Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis", Clin Interv Aging, 3, pp.211~225 (2008)
35. Birks J, "Cholinesterase inhibitors for Alzheimer's disease", Cochrane Database Syst Rev, pp.Cd005593~ (2006)
36. Areosa SA, "Memantine for dementia", Cochrane Database Syst Rev, pp.Cd003154~ (2003)
37. Leong C, "Antidepressants for depression in patients with dementia:a review of the literature", Consult Pharm, 29, pp.254~263 (2014)
38. Small GW, "Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society", Jama, 278, pp.1363~1371 (1997)
39. Cowdell F, "Preserving personhood in dementia research: a literature review", Int J Older People Nurs, 1, pp.85~94 (2006)
40. Yamaguchi H, "Overview of non-pharmacological intervention for dementia and principles of brain-activating rehabilitation", Psychogeriatrics, 10, pp.206~213 (2010)
41. Forbes D, "Exercise programs for people with dementia", Cochrane Database Syst Rev, 12, pp.Cd006489~ (2013)
42. National Collaborating Centre for Mental H, "Dementia: A NICE-SCIE Guideline on Supporting People With Dementia and Their Carers in Health and Social Care" (2007), British Psychological Society, The British Psychological Society & The Royal College of Psychiatrists
43. Streater A, "Maintenance Cognitive Stimulation Therapy (CST) in practice: study protocol for a randomized controlled trial", Trials, 13, pp.91~ (2012)
44. Bahar-Fuchs A, "Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia", Cochrane Database Syst Rev, 6, pp.CD003260~ (2013)
45. Choi J, "Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy", Neuropsychol Rev, 23, pp.48~62 (2013)
46. Hu JP, "Exercise improves cognitive function in aging patients", Int J Clin Exp Med, 7, pp.3144~3149 (2014)
47. Brown D, "Development of an exercise intervention to improve cognition in people with mild to moderate dementia: Dementia And Physical Activity (DAPA) Trial, registration ISRCTN32612072", Physiotherapy (2015)
48. Bossers WJ, "A 9-Week Aerobic and Strength Training Program Improves Cognitive and Motor Function in Patients with Dementia: A Randomized, Controlled Trial", Am J Geriatr Psychiatry (2015)
49. Chung C, "Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult nonprogressive acquired brain damage", Stroke, 44, pp.e77~e78 (2013)
50. Cicerone KD, "Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008", Arch Phys Med Rehabil, 92, pp.519~530 (2011)

관련 논문AI추천